Results 311 to 320 of about 182,106 (353)
Some of the next articles are maybe not open access.
Medicine, 2002
Diabetic nephropathy is diagnosed by the appearance of microalbuminuria and progresses to macroalbuminuria and end-stage kidney disease. Thus, it is important to estimate the urinary albumin excretion and glomerular filtration rates. The main targets of the treatment of diabetic nephropathy include hyperglycemia and glomerular hypertension. The results
Stephen Thomas, GianCarlo Viberti
openaire +5 more sources
Diabetic nephropathy is diagnosed by the appearance of microalbuminuria and progresses to macroalbuminuria and end-stage kidney disease. Thus, it is important to estimate the urinary albumin excretion and glomerular filtration rates. The main targets of the treatment of diabetic nephropathy include hyperglycemia and glomerular hypertension. The results
Stephen Thomas, GianCarlo Viberti
openaire +5 more sources
Current Opinion in Internal Medicine, 2003
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
Michael Mauer, Luiza M. Caramori
openaire +4 more sources
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
Michael Mauer, Luiza M. Caramori
openaire +4 more sources
Current therapy in endocrinology and metabolism, 1997
Diabetic nephropathy accounts for almost a third of all causes of ESRD. Microalbuminuria screening among diabetics can offer early detection of incipient nephropathy. Aggressive treatment with ACE inhibitors may delay the onset of overt renal failure or delay its progression.
CASTELLINO, Pietro +2 more
openaire +6 more sources
Diabetic nephropathy accounts for almost a third of all causes of ESRD. Microalbuminuria screening among diabetics can offer early detection of incipient nephropathy. Aggressive treatment with ACE inhibitors may delay the onset of overt renal failure or delay its progression.
CASTELLINO, Pietro +2 more
openaire +6 more sources
Clinical Cornerstone, 2003
As the epidemic of diabetes spreads so does the number of patients at risk for developing diabetic nephropathy, which occurs in 20% to 40% of all diabetic patients. Indeed, diabetes is the most common cause of end-stage renal disease (ESRD) in the United States, accounting for > 40% of patients starting renal replacement therapy each year ...
Mark E, Molitch +5 more
openaire +4 more sources
As the epidemic of diabetes spreads so does the number of patients at risk for developing diabetic nephropathy, which occurs in 20% to 40% of all diabetic patients. Indeed, diabetes is the most common cause of end-stage renal disease (ESRD) in the United States, accounting for > 40% of patients starting renal replacement therapy each year ...
Mark E, Molitch +5 more
openaire +4 more sources